Status:

COMPLETED

Gastric Layering and Monitoring II

Lead Sponsor:

Wageningen University

Collaborating Sponsors:

FrieslandCampina

Conditions:

Infant Formula

Eligibility:

MALE

18-45 years

Phase:

NA

Brief Summary

Rationale: Results from a previous study suggest that gastric layer formation, which is caused by emulsion instability as a result of gastric acidification/digestion, is different between breastmilk a...

Eligibility Criteria

Inclusion

  • Male
  • Apparently healthy (self-reported)
  • Willing to be informed about incidental findings of pathology
  • Willing to comply with the study procedures

Exclusion

  • Allergy or intolerance for cow milk, lactose, soy and/or fish (self-reported)
  • Gastric disorders or regular gastric complaints, for example heart burn
  • Use of medication which alters the normal functioning of the stomach, such as: Medical drug use that influences the GI tract's normal function, e.g. motility, pH etc.: among others use of protein pump inhibitors, antacids, anti-depressants etc. (judged by study doctor)
  • Medical drug use that influences the GI tract's microbiota: antibiotic use within one month prior to the pre-study screening day (judged by study doctor)
  • Smoking (\>2 cigarettes a week)
  • Drinking more than 14 glasses of alcohol a week
  • Having given a blood donation in the past two months
  • Hb value below 8.4 mmol/L (as measured with finger-prick method at screening)
  • Having a contra-indication to MRI scanning, including, but not limited to:
  • Pacemakers and defibrillators
  • Intraorbital or intraocular metallic fragments
  • Ferromagnetic implants
  • Claustrophobia
  • Participating in other research during the study period
  • Being an employee or student of the division of human nutrition and health
  • Not having a general practitioner

Key Trial Info

Start Date :

January 28 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 22 2022

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05224947

Start Date

January 28 2022

End Date

April 22 2022

Last Update

April 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wageningen University & Research

Wageningen, Gelderland, Netherlands, 6708WE